Skip to main content

Table 2 Time Course of Parameters after BAV in the MR Group

From: Mid-term effect of balloon aortic valvuloplasty on mitral regurgitation in aortic stenosis

 

Baseline

1 month after BAV

P value

3 months after BAV

P value

Clinical data

 NYHA III/IV, n (%)

28 (70.0)

1 (2.5)

< 0.001

1 (2.5)

< 0.001

Laboratory data

 BNP, pg/mL

702 (391–1042)

421 (206–618)

0.002

281 (182–401)

< 0.001

Conventional echo parameters

 LVEDD, mm

46.2 ± 6.0

45.4 ± 6.5

0.237

44.0 ± 6.8

0.033

 LVESD, mm

32.6 ± 6.8

31.2 ± 7.7

0.148

28.6 ± 7.0

< 0.001

 LVEF, %

51.4 ± 13.0

54.1 ± 10.1

0.089

57.4 ± 12.5

0.007

 LVSVI, mL

38.3 ± 11.7

41.3 ± 11.1

0.052

44.6 ± 11.2

0.002

 E/A

1.0 (0.6–1.6)

0.7 (0.6–1.0)

0.003

0.7 (0.5–0.9)

0.001

 E/e’

20.5 ± 8.7

15.5 ± 6.2

< 0.001

16.1 ± 7bnp.1

0.002

 TR-PG, mmHg

40.5 ± 15.4

29.7 ± 8.4

< 0.001

28.9 ± 6.4

< 0.001

 AR ≥ moderate, n (%)

5 (12.5)

6 (15.0)

1.000

4 (10.0)

1.000

AS parameters

 AVA, cm2

0.66 ± 0.17

0.84 ± 0.19

< 0.001

0.80 ± 0.20

0.001

 AVAi, cm2/m2

0.47 ± 0.12

0.59 ± 0.12

< 0.001

0.57 ± 0.12

< 0.001

 Peak V, m/s

61.0 ± 27.1

45.0 ± 19.1

< 0.001

51.7 ± 25.1

0.002

 mPG (mmHg)

35.6 ± 17.0

24.9 ± 11.5

< 0.001

29.8 ± 15.2

0.003

MR parameters

 MR jet area, cm2

6.3 (4.5–9.7)

3.5 (1.5–7.4)

< 0.001

2.1 (1.1–6.0)

< 0.001

 %MR, %

33.3 (22.6–42.7)

16.0 (8.9–34.3)

< 0.001

12.0 (4.7–29.4)

< 0.001

 Mitral annular dimension, mm

28.5 ± 4.9

27.2 ± 4.2

0.030

25.5 ± 3.3

< 0.001

 Tenting height, mm

4.1 ± 1.9

3.8 ± 1.9

0.307

2.8 ± 1.1

< 0.001

 Tenting area, mm2

58.8 ± 31.6

52.0 ± 28.5

0.169

35.5 ± 14.5

< 0.001